I agree that this site is using cookies. You can find further informations here.
X
Goss, Glenwood D.
107  results:
Search for persons X
?
1

Biomarker-directed targeted therapy plus durvalumab in adva..:

Besse, Benjamin ; Pons-Tostivint, Elvire ; Park, Keunchil...
Nature Medicine.  30 (2024)  3 - p. 716-729 , 2024
Link: https://doi.org/10.1038/..
 
?
2

Histologic and Genotypic Characterization of Lung Cancer in..:

Goss, Glenwood D. ; Spaans, Johanna N. ; Huntsman, David...
Current Oncology.  29 (2022)  5 - p. 3171-3186 , 2022
Link: https://doi.org/10.3390/..
 
?
3

CCTG BR34: A Randomized Phase 2 Trial of Durvalumab and Tre..:

Leighl, Natasha B. ; Laurie, Scott A. ; Goss, Glenwood D....
Journal of Thoracic Oncology.  17 (2022)  3 - p. 434-445 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Tumor genomic, transcriptomic, and immune profiling charact..:

Weberpals, Johanne I. ; Pugh, Trevor J. ; Marco‐Casanova, Paola...
Cancer Medicine.  10 (2021)  9 - p. 3045-3058 , 2021
Link: https://doi.org/10.1002/..
 
?
5

Fe3O4 Nanoparticles and Paraffin Wax as Phase Change Materi..:

Cohen-Erner, Moshe ; Khandadash, Raz ; Hof, Raphael...
ACS Applied Nano Materials.  4 (2021)  10 - p. 11187-11198 , 2021
Link: https://doi.org/10.1021/..
 
?
6

Novel Nanoparticle-Based Cancer Treatment, Effectively Inhi..:

Kraus, Sarah ; Khandadash, Raz ; Hof, Raphael...
Frontiers in Oncology.  11 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
7

Afatinib versus erlotinib as second-line treatment of patie..:

Goss, Glenwood D. ; Cobo, Manuel ; Lu, Shun...
eClinicalMedicine.  37 (2021)  - p. 100940 , 2021
Link: https://doi.org/10.1016/..
 
?
8

A novel, more reliable approach to use of progression-free ..:

Stewart, David J. ; Bossé, Dominick ; Goss, Glenwood...
Critical Reviews in Oncology/Hematology.  148 (2020)  - p. 102896 , 2020
Link: https://doi.org/10.1016/..
 
?
9

A phase IB study of durvalumab with or without tremelimumab..:

Juergens, Rosalyn A. ; Hao, Desiree ; Ellis, Peter M....
Lung Cancer.  143 (2020)  - p. 1-11 , 2020
Link: https://doi.org/10.1016/..
 
?
10

Inpatients versus outpatients with advanced non-small cell ..:

Gotfrit, Joanna ; Jonker, Caleb ; Zhang, Tinghua...
Cancer Treatment and Research Communications.  19 (2019)  - p. 100130 , 2019
Link: https://doi.org/10.1016/..
 
?
11

Selumetinib in patients receiving standard pemetrexed and p..:

Melosky, Barbara ; Bradbury, Penelope ; Tu, Dongsheng...
Lung Cancer.  133 (2019)  - p. 48-55 , 2019
Link: https://doi.org/10.1016/..
 
?
12

Update on International Cooperative Groups Studies in Thora..:

Shukla, Navika D. ; Salahudeen, Ameen A. ; Taylor, Gregory A....
Clinical Lung Cancer.  19 (2018)  5 - p. 377-386 , 2018
Link: https://doi.org/10.1016/..
 
?
13

Efficacy and safety results of depatuxizumab mafodotin (ABT..:

Goss, Glenwood D. ; Vokes, Everett E. ; Gordon, Michael S....
Cancer.  124 (2018)  10 - p. 2174-2183 , 2018
Link: https://doi.org/10.1002/..
 
?
14

Osimertinib in patients with T790M mutation‐positive, advan..:

Ahn, Myung‐Ju ; Tsai, Chun‐Ming ; Shepherd, Frances A....
Cancer.  125 (2018)  6 - p. 892-901 , 2018
Link: https://doi.org/10.1002/..
 
?
15

Symptom and Quality of Life Improvement in LUX-Lung 8, an O..:

Felip, Enriqueta ; Hirsh, Vera ; Popat, Sanjay...
Clinical Lung Cancer.  19 (2018)  1 - p. 74-83.e11 , 2018
Link: https://doi.org/10.1016/..
 
1-15